1. Home
  2. SINT vs EDSA Comparison

SINT vs EDSA Comparison

Compare SINT & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SiNtx Technologies Inc.

SINT

SiNtx Technologies Inc.

HOLD

Current Price

$2.84

Market Cap

12.5M

Sector

Health Care

ML Signal

HOLD

Logo Edesa Biotech Inc.

EDSA

Edesa Biotech Inc.

HOLD

Current Price

$1.17

Market Cap

12.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SINT
EDSA
Founded
1996
2015
Country
United States
Canada
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.5M
12.3M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
SINT
EDSA
Price
$2.84
$1.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$16.00
$13.00
AVG Volume (30 Days)
35.8K
95.6K
Earning Date
03-18-2026
02-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,270,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$80.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.71
$0.94
52 Week High
$7.36
$4.49

Technical Indicators

Market Signals
Indicator
SINT
EDSA
Relative Strength Index (RSI) 24.47 30.21
Support Level $3.53 $0.94
Resistance Level $3.94 $1.34
Average True Range (ATR) 0.14 0.12
MACD -0.06 -0.03
Stochastic Oscillator 6.32 31.63

Price Performance

Historical Comparison
SINT
EDSA

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

Share on Social Networks: